Friday, November 20, 2026
Freedom Online
  • Home
  • News
    • Foreign
    • Crime
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates
No Result
View All Result
Freedom Online
  • Home
  • News
    • Foreign
    • Crime
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates
No Result
View All Result
Freedom Online
No Result
View All Result

NAFDAC notifies Nigerians on fake anti-malaria drug in circulation

Robert Imoh by Robert Imoh
November 30, 2024
in News
0
Share on FacebookShare on TwitterShare on Whatsapp

The National Agency for Food and Drug Administration and Control (NAFDAC) has notified the general public of the sale of counterfeit combiart (Artemether Lumefantrine 20/120mg) Dispersible Tablet in Nigeria.

The notification is in a public alert marked: No. 043/2024, issued on NAFDAC website, disclosing the date of manufacturing of the drug to be Feb. 2023 and June 2023.

It equally gave the expiring date of the drug as May 2026 and June 2026, as well as Batch No: 7225119 with NAFDAC Reg No: A11-0299.

The agency equally gave the manufacturer name and address as Strides Arcolab Limited, 36/7, Suragajakkanahalli, Indlavadi Cross, Anekal Taluk, Bangalore- 562 106, India.

NAFDAC, in the alert, said that all its zonal directors and state coordinators had been directed to carry out surveillance and mop up the counterfeit products within the zones and states.

It advised importers, distributors, retailers, healthcare professionals, and caregivers to exercise caution and vigilance within the supply chain and avoid importation, distribution, sale, and usage of the counterfeit product.

It said that all medical products must be obtained from authorised/licenced suppliers and that products’ authenticity and physical condition must be carefully checked.

The alert also advised healthcare professionals and consumers to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office.

It urged Nigerians to call NAFDAC on 0800-162-3322 or report any suspicion event via email: [email protected].

“Healthcare professionals and patients are similarly encouraged to report adverse or side effects related to the use of medicinal products or devices to the nearest NAFDAC office, or through E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng.,” it said

It advised Nigerians to reports any adverse effects via the Med-safety application available for download on android and IOS stores or via e-mail on [email protected].

NAFDAC promised that the notice would be uploaded to the WHO Global Surveillance and Monitoring System (GSMS)

 

Share25Tweet16Send
Previous Post

CBN reforms support strong, resilient African financial architecture- Cardoso

Next Post

Minimum Wage: C’River workers set for strike

Next Post

Minimum Wage: C’River workers set for strike

Solidaridad, others synergise on oil palm traceability in Nigeria

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

https://freedomonline.com.ng/wp-content/uploads/2026/04/VID-20260408-WA0025.mp4
https://freedomonline.com.ng/wp-content/uploads/2025/01/5aeac180-db4e-4e7c-bd37-07ddbf15b053.mp4

Popular Stories

Plugin Install : Popular Post Widget need JNews - View Counter to be installed

Latest Stories

Wike Defends SUVs for FCT Traditional Rulers, Promises Palaces in 2027 Budget

November 20, 2026

Moniepoint MFB Records N1 Trillion in Daily Transactions, Serves 21 Million Customers

November 20, 2026
Screenshot

Experts Urge Men to Speak Up on Erectile Dysfunction, Mental Health Challenges

November 20, 2026

UNICEF Urges Kano, Jigawa, Katsina to Prioritise Children’s Rights in Budgets

November 20, 2026

Infantino Urges Hussey College to Maximise New Sports Complex for Football Talent Development

November 20, 2026

Tinubu Appoints Agboola Dabiri as South-West Commissioner in NASS Service Commission

November 20, 2026

Oshiomhole Backs Tinubu’s Re-election Bid, Cites Passport Reforms as Evidence

November 20, 2026
Freedom Online

© 2026 Published by SWAAYA LIMITED, Plot 20, Block G, Scheme 1, Residential 3, OPIC Beachland Estate, Lagos/Ibadan Expressway, Lagos. Gabriel Akinadewo, MD/CEO 08023010222, 08094000056, 08052097814.

Navigate Site

  • Home
  • News
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates

Follow Us

No Result
View All Result

© 2026 Published by SWAAYA LIMITED, Plot 20, Block G, Scheme 1, Residential 3, OPIC Beachland Estate, Lagos/Ibadan Expressway, Lagos. Gabriel Akinadewo, MD/CEO 08023010222, 08094000056, 08052097814.